secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001193125-23-142017
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics issues $460M of 1.50% convertible notes due 2028; enters capped call transactions
--------------------------------------------------------------------------------

- Issued $460M aggregate principal of 1.50% Convertible Senior Notes due 2028, including full exercise of $60M greenshoe.
- Initial conversion price ~$94.00/share, a 32.5% premium over May 8 closing price of $70.94.
- Notes mature June 1, 2028; interest payable semi-annually at 1.50% per annum.
- Entered capped call transactions covering ~4.89M shares to reduce potential dilution upon conversion.
- Notes sold in private placement to QIBs under Rule 144A; not registered under Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523142017/0001193125-23-142017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523142017/d509646d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-142017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer